Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL2576561 | 0.99 | AGTR1 (0.60) | AGTR1AGTR2 | |
| SCHEMBL3342427 | 0.99 | AGTR1 (0.60) | AGTR1AGTR2 | |
| SCHEMBL7308729 | 0.95 | AGTR2 (0.55) | AGTR1AGTR2 | |
| SCHEMBL7303815 | 0.93 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL8845378 | 0.93 | AGTR1 (0.51) | AGTR1AGTR2 | |
| SCHEMBL1988060 | 0.91 | AGTR1 (0.53) | AGTR1AGTR2 | |
| SCHEMBL7308562 | 0.89 | AGTR1 (0.47) | AGTR1AGTR2 | |
| SCHEMBL7886538 | 0.89 | AGTR1 (0.48) | AGTR1AGTR2 | |
| SCHEMBL7304485 | 0.88 | AGTR1 (0.53) | AGTR1 | |
| SCHEMBL7297184 | 0.88 | AGTR1 (0.50) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1910343-B1 | PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL | KRKA (SI) | 2014-10-29 | — | — | EP | claimed |
| CN-110396084-B | Method for preparing high-purity trityl olmesartan medoxomil | 连云港润众制药有限公司 | 2023-01-20 | — | — | CN | disclosed |
| US-8076492-B2 | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil | CIPLA LIMITED (IN) | 2011-12-13 | — | — | US | disclosed |
| US-8048904-B2 | Process for the preparation of olmesartan medoxomil | MATRIX LABORATORIES LTD. (IN) | 2011-11-01 | — | — | US | disclosed |
| EP-2334668-A1 | PROCESS FOR PREPARING OLMESARTAN MEDOXOMIL INTERMEDIATE | Krka Tovarna Zdravil, D.D., Novo Mesto (SI) | 2011-06-22 | — | — | EP | disclosed |
| US-20100160643-A1 | Process for Preparing Trityl Olmesartan Medoxomil and Olmesartan Medoxomil | CIPLA LIMITED (IN) | 2010-06-24 | — | — | US | disclosed |
| WO-2010026255-A1 | PROCESS FOR PREPARING OLMESARTAN MEDOXOMIL INTERMEDIATE | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2010-03-11 | — | — | WO | disclosed |
| US-20090281327-A1 | PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL | MATRIX PHARMACORP PRIVATE LIMITED (IN) | 2009-11-12 | — | — | US | disclosed |
| EP-2074116-A2 | PROCESS FOR PREPARING TRITYL OLMESARTAN MEDOXOMIL AND OLMESARTAN MEDOXOMIL | Cipla Limited (IN) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008043996-A2 | PROCESS FOR PREPARING TRITYL OLMESARTAN MEDOXOMIL AND OLMESARTAN MEDOXOMIL | CIPLA LIMITED (IN) | 2008-04-17 | — | — | WO | disclosed |
| EP-0503785-B1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | SANKYO CO (JP) | 2001-04-25 | — | — | EP | disclosed |
| US-5646171-A | HYPOTENSIVE AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-07-08 | — | — | US | disclosed |
| US-5616599-A | HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER | SANKYO COMPANY, LIMITED (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0503785-A1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1992-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160643-A1 | Process for Preparing Trityl Olmesartan Medoxomil and Olmesartan Medoxomil | MED1, AGTR1, MED12 | AGTR1 2/4885AGTR2 4/4885 |
| US-20090281327-A1 | PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL | MED1, TET1, AGTR1 | AGTR1 3/4885AGTR2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.